12,771 reports of this reaction
2.4% of all ALENDRONATE SODIUM reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for ALENDRONATE SODIUM, manufactured by Organon LLC. There are 12,771 FDA adverse event reports linking ALENDRONATE SODIUM to FATIGUE. This represents approximately 2.4% of all 542,544 adverse event reports for this drug.
Patients taking ALENDRONATE SODIUM who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for ALENDRONATE SODIUM, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for ALENDRONATE SODIUM:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 12,771 FDA reports for ALENDRONATE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.4% of all adverse event reports for ALENDRONATE SODIUM, making it one of the most commonly reported side effect.
If you experience fatigue while taking ALENDRONATE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.